NebraskaEffective Treatment Quality Measures Compared to Achievable Benchmarks

The NHQDR quality measures specific to Effective Treatment are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For example, low values are desirable for measures such as infant mortality, whereas high values are desirable for measures such as preventative screening. The categories of achievement have been standardized across the measure definitions so that:

 
Far away from benchmark - a State's value for a measure has not achieved 50% of the benchmark.
 
Close to benchmark - a State's value for a measure is between 50% and 90% of a benchmark (i.e., worse than the benchmark but has achieved at least half of the benchmark but not as much as 90% of a benchmark).
 
Achieved benchmark or better - a State's value for a measure is no worse than 90% of the benchmark value, the measure has achieved the benchmark. This category also includes the case in which the measure’s value is equal to or better than the benchmark.
Measures That Achieved Benchmark or Better
Measure Estimate Benchmark Distance to Benchmark
Drug overdose deaths involving any opioid per 100,000 resident population 3.1 4.0 Achieved: 23% better
Drug overdose deaths involving natural and semisynthetic opioids per 100,000 resident population 1.7 1.9 Achieved: 10% better
People age 12 and over treated for substance abuse who completed treatment course 66.0 65.2 Achieved: 1% better
Short-stay home health patients who had diabetic foot care and patient education 97.9 98.6 0.7%
Adult hemodialysis patients with adequate dialysis - (Kt/V) 12 or higher 95.6 96.5 0.9%
Stroke patients who received venous thromboembolism (VTE) prophylaxis 97.0 98.7 1.8%
Women under age 70 treated for breast cancer with breast-conserving surgery who received radiation therapy to the breast within 1 year of diagnosis 94.9 97.0 2.2%
Ratio of observed deaths to expected deaths among Medicare hemodialysis patients 0.9 0.9 2.4%
Stroke patients prescribed statin medication at hospital discharge 96.2 98.6 2.4%
Women with clinical Stage I-IIb breast cancer who received axillary node dissection or sentinel lymph node biopsy (SLNB) at the time of surgery (lumpectomy or mastectomy) 93.3 96.8 3.6%
Stroke patients with educational material addressing activation of emergency medical system, follow-up after discharge, educations prescribed at discharge, risk factors for stroke, warning signs and symptoms of stroke 92.4 96.7 4.4%
Patients with colon cancer who received surgical resection of colon cancer that included at least 12 lymph nodes pathologically examined 90.7 95.3 4.8%
Adults age 40 and over with diagnosed diabetes who received a flu vaccination in the calendar year 62.0 65.8 5.8%
Adults age 40 and over with diagnosed diabetes who had their feet checked for sores or irritation in the calendar year 78.6 84.0 6.5%
Patients with treated chronic kidney failure who received a transplant within 3 years of date of renal failure 26.9 28.8 6.6%
Persons age 13 and over living with HIV who know their serostatus 85.1 91.9 7.4%
Measures That Are Close to Benchmark
Measure Estimate Benchmark Distance to Benchmark
Acute stroke patients for whom IV thrombolytic therapy was initiated at hospital within 3 hours of time last known well 83.2 92.9 10.5%
Adults age 40 and over with diagnosed diabetes who received at least two hemoglobin A1c measurements in the calendar year 70.4 79.5 11.4%
Adults age 40 and over with diagnosed diabetes who received a dilated eye examination in the calendar year 65.8 75.2 12.5%
Breast cancer deaths per 100,000 female population per year 20.1 17.8 13.0%
Adult hemodialysis patients who use arteriovenous fistulas as the primary mode of vascular access 61.3 72.8 15.8%
Dialysis patients who were registered on a waiting list for transplantation 22.3 28.2 20.9%
Persons age 13 and over living with diagnosed HIV whose most recent viral load in the last 12 months was under 200 copies/mL 60.2 76.1 20.9%
Colorectal cancer deaths per 100,000 population per year 14.2 11.5 23.1%
New HIV cases per 100,000 population age 13 and over 5.2 4.2 23.8%
Persons age 13 and over living with diagnosed HIV who had at least two CD4 or viral load tests performed at least 3 months apart during the last year, among reporting jurisdictions 49.3 66.2 25.6%
Adult end stage renal disease (ESRD) patients who saw a nephrologist at least 12 months prior to initiation of renal replacement therapy 37.4 54.1 30.8%
Emergency department visits involving opioid-related diagnoses per 100,000 population 85.8 65.2 31.5%
Lung cancer deaths per 100,000 population per year 37.5 27.5 36.6%
Measures That Are Far From Benchmark
Measure Estimate Benchmark Distance to Benchmark
Hospital inpatient stays involving opioid-related diagnoses per 100,000 population 160.2 102.9 55.7%
Suicide deaths among persons age 12 and over per 100,000 population 15.8 9.4 68.4%
Drug overdose deaths involving other synthetic opioids (other than methadone) per 100,000 resident population 1.3 0.7 78.1%
Long-stay nursing home residents have depressive symptoms 4.4 1.1 283.5%
Measures With No Available Benchmark Information or Supplemental Measures
Measure Estimate Benchmark Distance to Benchmark
Tamoxifen or third generation aromatase inhibitor was recommended or administered within 1 year of diagnosis for women with AJCC T1cN0M0 or stage IB to stage III hormone receptor-positive breast cancer 90.3
Median time in minutes before outpatients with chest pain or possible heart attack who needed specialized care were transferred to another hospital and did not have contraindication to fibrinolytic 60.0
Median time in minutes outpatients with chest pain or possible heart attack who got drugs to break up blood clots after arrival 30.0
Median time in minutes outpatients with chest pain or possible heart attack from emergency department arrival to get ECG 7.0
Outpatients with chest pain or possible heart attack who received fibrinolytic therapy within 30 minutes of arrival 50.7
Combination chemotherapy was recommended or administered within 4 months of diagnosis for women under 70 with AJCC T1cN0MO or Stage IB-III hormone receptor negative breast cancer 91.7
Adjuvant chemotherapy was recommended or administered within 4 months of diagnosis for patients under the age of 80 with AJCC Stage III lymph node positive colon cancer 85.4
Composite measure: Cancer deaths per 100,000 population per year for all cancers 153.6
Patients who came to the emergency department (ED) with stroke symptoms and received head CT or MRI who received the interpretation of the results within 45 minutes of ED arrival 78.0
Percent of hemodialysis patients whose hemoglobin level is less than 10 g/dL 12.7
New AIDS cases per 100,000 population age 13 and over 3.0
Patients with end stage renal disease due to diabetes 47.3